In This Section
Society of Nuclear Medicine and Molecular Imaging Announces 2023 Fellows
June 26, 2023
Chicago, Illinois – The Society of Nuclear Medicine and Molecular Imaging recognized ten new SNMMI Fellows today during a plenary session at the society’s 2023 Annual Meeting, held June 24-27. The SNMMI Fellowship was established in 2016 to recognize distinguished service to the society as well as exceptional achievement in the field of nuclear medicine and molecular imaging. It is among the most prestigious formal recognitions available to long-time SNMMI members.
In keeping with tradition, SNMMI’s 2022-23 president, Munir Ghesani, MD, FACNM, FACR, Mount Sinai Hospital, New York, New York, was honored as an SNMMI Fellow following his term. Also recognized were:
Ramsey Badawi, PhD, University of California Davis Health, Sacramento, California
Erin Grady, MD, CCD, FACNM, Stanford University Medical Center, Stanford, California
John Hoffman, MD, University of Utah School of Medicine, Salt Lake City, Utah
Andrei Iagaru, MD, Stanford University Medical Center, Stanford, California
Martin Pomper, MD, PhD, Johns Hopkins University School of Medicine, Baltimore, Maryland
Arman Rahmim, PhD, University of British Columbia, Vancouver, British Columbia, Canada
Barry Shulkin, MD, St. Jude Children’s Research Hospital, Memphis, Tennessee
Gary Ulaner, MD, PhD, FACNM, Hoag Family Cancer Institute, Irvine, California
In addition, Virginia Pappas, CAE, SNMMI CEO, will be recognized as an honorary Fellow for her many years of service to the society.
 |
| From left: Munir Ghesani, MD, FACNM, FACR; Ramsey Badawi, PhD; Erin Grady, MD, CCD, FACNM; Andrei Iagaru, MD; Arman Rahmim, PhD; Barry Shulkin, MD; Gary Ulaner, MD, PhD, FACNM; Virginia Pappas, CAE; Helen Nadel, MD, FRCPC; Cathy Cutler, PhD, FSNMMI |
Selection of SNMMI Fellows is based on documented excellence of volunteer service to the society and at least one of the additional three areas: excellence in scientific discovery and innovation, educational efforts in nuclear medicine and molecular imaging, or clinical practice of nuclear medicine and molecular imaging. SNMMI Fellowship is recognized with the designation FSNMMI.
###
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.